Safety and efficacy are paramount in drug development. Epidemiologists use randomized controlled trials (RCTs) to minimize bias and ensure reliable results. Additionally, cohort and case-control studies can provide insights into long-term effects and rare adverse events. Post-marketing surveillance further ensures that any unforeseen issues are promptly addressed.
